Associations of unprocessed and processed meat intake with mortality and cardiovascular disease in 21 countries [Prospective Urban Rural Epidemiology (PURE) Study]: a prospective cohort study.


Journal

The American journal of clinical nutrition
ISSN: 1938-3207
Titre abrégé: Am J Clin Nutr
Pays: United States
ID NLM: 0376027

Informations de publication

Date de publication:
01 09 2021
Historique:
received: 06 08 2020
accepted: 29 12 2020
pubmed: 1 4 2021
medline: 2 10 2021
entrez: 31 3 2021
Statut: ppublish

Résumé

Dietary guidelines recommend limiting red meat intake because it is a major source of medium- and long-chain SFAs and is presumed to increase the risk of cardiovascular disease (CVD). Evidence of an association between unprocessed red meat intake and CVD is inconsistent. The study aimed to assess the association of unprocessed red meat, poultry, and processed meat intake with mortality and major CVD. The Prospective Urban Rural Epidemiology (PURE) Study is a cohort of 134,297 individuals enrolled from 21 low-, middle-, and high-income countries. Food intake was recorded using country-specific validated FFQs. The primary outcomes were total mortality and major CVD. HRs were estimated using multivariable Cox frailty models with random intercepts. In the PURE study, during 9.5 y of follow-up, we recorded 7789 deaths and 6976 CVD events. Higher unprocessed red meat intake (≥250 g/wk vs. <50 g/wk) was not significantly associated with total mortality (HR: 0.93; 95% CI: 0.85, 1.02; P-trend = 0.14) or major CVD (HR: 1.01; 95% CI: 0.92, 1.11; P-trend = 0.72). Similarly, no association was observed between poultry intake and health outcomes. Higher intake of processed meat (≥150 g/wk vs. 0 g/wk) was associated with higher risk of total mortality (HR: 1.51; 95% CI: 1.08, 2.10; P-trend = 0.009) and major CVD (HR: 1.46; 95% CI: 1.08, 1.98; P-trend = 0.004). In a large multinational prospective study, we did not find significant associations between unprocessed red meat and poultry intake and mortality or major CVD. Conversely, a higher intake of processed meat was associated with a higher risk of mortality and major CVD.

Sections du résumé

BACKGROUND
Dietary guidelines recommend limiting red meat intake because it is a major source of medium- and long-chain SFAs and is presumed to increase the risk of cardiovascular disease (CVD). Evidence of an association between unprocessed red meat intake and CVD is inconsistent.
OBJECTIVE
The study aimed to assess the association of unprocessed red meat, poultry, and processed meat intake with mortality and major CVD.
METHODS
The Prospective Urban Rural Epidemiology (PURE) Study is a cohort of 134,297 individuals enrolled from 21 low-, middle-, and high-income countries. Food intake was recorded using country-specific validated FFQs. The primary outcomes were total mortality and major CVD. HRs were estimated using multivariable Cox frailty models with random intercepts.
RESULTS
In the PURE study, during 9.5 y of follow-up, we recorded 7789 deaths and 6976 CVD events. Higher unprocessed red meat intake (≥250 g/wk vs. <50 g/wk) was not significantly associated with total mortality (HR: 0.93; 95% CI: 0.85, 1.02; P-trend = 0.14) or major CVD (HR: 1.01; 95% CI: 0.92, 1.11; P-trend = 0.72). Similarly, no association was observed between poultry intake and health outcomes. Higher intake of processed meat (≥150 g/wk vs. 0 g/wk) was associated with higher risk of total mortality (HR: 1.51; 95% CI: 1.08, 2.10; P-trend = 0.009) and major CVD (HR: 1.46; 95% CI: 1.08, 1.98; P-trend = 0.004).
CONCLUSIONS
In a large multinational prospective study, we did not find significant associations between unprocessed red meat and poultry intake and mortality or major CVD. Conversely, a higher intake of processed meat was associated with a higher risk of mortality and major CVD.

Identifiants

pubmed: 33787869
pii: S0002-9165(22)00428-2
doi: 10.1093/ajcn/nqaa448
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1049-1058

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the American Society for Nutrition.

Auteurs

Romaina Iqbal (R)

Department of Community Health Sciences and Medicine, Aga Khan University, Karachi, Pakistan.

Mahshid Dehghan (M)

McMaster University, Population Health Research Institute, Hamilton, Ontario, Canada.

Andrew Mente (A)

McMaster University, Population Health Research Institute, Hamilton, Ontario, Canada.

Sumathy Rangarajan (S)

McMaster University, Population Health Research Institute, Hamilton, Ontario, Canada.

Andreas Wielgosz (A)

Department of Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

Alvaro Avezum (A)

International Research Centre, Hospital Alemao Oswaldo Cruz, University of Santo Amaro (UNISA), Sao Paulo, SP Brazil.

Pamela Seron (P)

Faculty of Medicine, University of La Frontera, Temuco, Chile.

Khalid F AlHabib (KF)

Department of Cardiac Sciences, King Fahad Cardiac Center, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Patricio Lopez-Jaramillo (P)

Masira Research Institute, Medical School, University of Santander, Bucaramanga, Colombia.

Sumathi Swaminathan (S)

Division of Nutrition, St John's Research Institute, Koramangala, Bangalore, India.

Noushin Mohammadifard (N)

Isfahan University of Medical Sciences, Isfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan, Iran.

Katarzyna Zatońska (K)

Department of Medicine, Wroclaw Medical University, Wroclaw, Poland.

Hu Bo (H)

Medical Research and Biometrics Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

Ravi Prasad Varma (RP)

Health Action by People, Thiruvananthapuram and Achutha Menon Center for Health Science Studies, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, India.

Omar Rahman (O)

University of Liberal Arts, Dhaka, Bangladesh.

AfzalHussein Yusufali (A)

Dubai Medical University, Hatta Hospital, Dubai Health Authority, Dubai, United Arab Emirates.

Yin Lu (Y)

Medical Research and Biometrics Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

Noorhassim Ismail (N)

Department of Community Health, Faculty of Medicine, University Kebangsaan Malaysia, Kuala Lumpur, Malaysia.

Annika Rosengren (A)

University of Gothenburg and Region Västra Götaland, Sahlgrenska University Hospital, Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, Gothenburg, Sweden.

Neşe Imeryuz (N)

Department of Internal Medicine and Gastroenterology, School of Medicine, Marmara University, Istanbul, Turkey.

Karen Yeates (K)

Queen's University, Department of Medicine, Canada and Pamoja Tunaweza Research Center, Moshi, Tanzania.

Jephat Chifamba (J)

University of Zimbabwe College of Health Sciences, Harare, Zimbabwe.

Antonio Dans (A)

Department of Medicine, University of the Philippines, Manila, Philippines.

Rajesh Kumar (R)

Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Liu Xiaoyun (L)

Medical Research and Biometrics Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

Lungi Tsolekile (L)

School of Public Health, University of the Western Cape, Bellville, South Africa.

Rasha Khatib (R)

Birzeit University, Institute for Community and Public Health, Birzeit, Palestine.
Advocate Research Institute, Advocate Health Care, Chicago, IL, USA.

Rafael Diaz (R)

Clinical Studies Latin America, Rosario, Santa Fe, Argentina.

Koon Teo (K)

McMaster University, Population Health Research Institute, Hamilton, Ontario, Canada.

Salim Yusuf (S)

McMaster University, Population Health Research Institute, Hamilton, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH